Fintel reports that on October 5, 2023, JP Morgan maintained coverage of Walgreens Boots Alliance (NASDAQ:WBA) with a Neutral recommendation.
Analyst Price Forecast Suggests 38.38% Upside
As of October 5, 2023, the average one-year price target for Walgreens Boots Alliance is 30.68. The forecasts range from a low of 22.22 to a high of $47.25. The average price target represents an increase of 38.38% from its latest reported closing price of 22.17.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Walgreens Boots Alliance is 142,546MM, an increase of 4.73%. The projected annual non-GAAP EPS is 4.84.
What is the Fund Sentiment?
There are 1867 funds or institutions reporting positions in Walgreens Boots Alliance. This is a decrease of 140 owner(s) or 6.98% in the last quarter. Average portfolio weight of all funds dedicated to WBA is 0.20%, a decrease of 23.19%. Total shares owned by institutions decreased in the last three months by 0.18% to 550,925K shares. 
The put/call ratio of WBA is 0.65, indicating a bullish outlook.
What are Other Shareholders Doing?
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 22,886K shares representing 2.65% ownership of the company. In it's prior filing, the firm reported owning 22,699K shares, representing an increase of 0.81%. The firm decreased its portfolio allocation in WBA by 23.36% over the last quarter.
Capital World Investors holds 19,629K shares representing 2.27% ownership of the company. In it's prior filing, the firm reported owning 19,569K shares, representing an increase of 0.31%. The firm decreased its portfolio allocation in WBA by 23.10% over the last quarter.
VFINX - Vanguard 500 Index Fund Investor Shares holds 17,050K shares representing 1.98% ownership of the company. In it's prior filing, the firm reported owning 16,704K shares, representing an increase of 2.03%. The firm decreased its portfolio allocation in WBA by 23.83% over the last quarter.
Geode Capital Management holds 15,808K shares representing 1.83% ownership of the company. In it's prior filing, the firm reported owning 13,434K shares, representing an increase of 15.01%. The firm decreased its portfolio allocation in WBA by 12.27% over the last quarter.
Invesco holds 14,013K shares representing 1.62% ownership of the company. In it's prior filing, the firm reported owning 14,319K shares, representing a decrease of 2.19%. The firm increased its portfolio allocation in WBA by 718.56% over the last quarter.
Walgreens Boots Alliance Background Information
(This description is provided by the company.)
Walgreens Boots Alliance is a global leader in retail and wholesale pharmacy, touching millions of lives every day through dispensing and distributing medicines, and through its convenient retail locations, digital platforms and health and beauty products. The company has more than 100 years of trusted health care heritage and innovation in community pharmacy and pharmaceutical wholesaling. Including equity method investments, WBA has a presence in more than 25 countries, employs more than 450,000 people and has more than 21,000 stores. WBA's purpose is to help people across the world lead healthier and happier lives. The company is proud of its contributions to healthy communities, a healthy planet, an inclusive workplace and a sustainable marketplace. WBA is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. WBA is included in FORTUNE's 2020 list of the World's Most Admired Companies*, ranked first in the food and drugstore category. This is the 27th consecutive year that WBA or its predecessor company, Walgreen Co., has been named to the list.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
